bioRxiv Science⌕ Search

Biology subjects

Vuillefroy de Silly, R.

Publications and source records attributed to Vuillefroy de Silly, R..

2 recordsLinked to original sources

Acidity-induced dysfunction of CD8+ T cells is characterized by impaired IL-2 responsiveness and perturbations to mTORC1 signaling and c-Myc levels

CD8+ T cells play a critical role in cancer control but a range of barriers in the tumor microenvironment, including low pH, can impair their function. Here, we demonstrate that acidity dampens T-cell expansion mainly due to impaired IL-2 responsiveness, blunts cytokine secretion upon re-activation, and lowers the cytolytic capacity of CD8+ T cells expressing weak affinity TCR. We further reveal and dissect defects in both mTORC1 activity and c-Myc accumulation at low pH, the latter of which is largely due to proteasome-mediated degradation. In addition, lower intracellular levels of glutamine, glutamate and aspartate as well as elevated proline were noted, with no apparent impact on mTORC1 or c-Myc. Overall, low pH disrupts diverse intracellular signaling pathways as well as nutrient uptake/processing by T cells and we conclude that unless intracellular pH can be restored, multiple interventions will be required to overcome acidity-induced dysfunction.

cell biology↗

Transcriptional reprogramming by IL-2 variant generates metabolically active stem-like T cells

Interleukin-2 receptor (IL-2R)-mediated intracellular signaling is a key regulator of T-cell fate decisions. While the potent signals generated by IL-2 engagement execute effector differentiation, elevated metabolic activities and rapid cellular expansion, IL-15 binding induces a stemness/memory phenotype and a quiescent metabolic state. Here, we demonstrate that weak but sustained signaling generated by a non-IL-2R-binding variant of IL-2 (IL-2v) drive proliferation/metabolic and stemness transcriptional programs, thereby reprogramming CD8+ T cells into a hybrid metabolically active stem-like state. We further show that IL-2v-induced T cells are capable of superior engraftment, persistence, and tumor control when utilized in adoptive cell therapy. Taken together, our study highlights the ability to fine-tune cytokine engagement of cognate receptors in order to generate therapeutically relevant T-cell states and further reveals the metabolic plasticity of the T-cell memory program.

systems biology↗